Advertisement

Clinical Journal of Gastroenterology

, Volume 12, Issue 2, pp 112–119 | Cite as

An intensive medical care network led to successful living-donor liver transplantation in late-onset hepatic failure with disseminated Staphylococcus aureus infection

  • Rie Kure
  • Natsumi Uehara
  • Kazuaki InoueEmail author
  • Tomomi KogisoEmail author
  • Kazuhisa Kodama
  • Makiko Taniai
  • Katsutoshi Tokushige
  • Masayuki Nakano
  • Hiroto Egawa
  • Masakazu Yamamoto
Case Report
  • 60 Downloads

Abstract

Here, we describe a 42-year-old male patient with late-onset hepatic failure (LOHF) due to acute-onset autoimmune hepatitis. At first, his response to steroid therapy was good, but hepatitis relapsed during steroid pulse therapy. Deterioration of liver function caused LOHF, and LOHF has a poor prognosis, particularly when it is complicated by infection. Systemic infection by Staphylococcus aureus resulted in a skin rash and septic pulmonary embolism, and is an absolute contraindication for liver transplantation (LT). In this treatment network, hepatologists and a transplant surgeon cooperated to overcome severe infection and their efforts led to successful transplantation. On-line hemodiafiltration is an indispensable treatment option for acute liver failure. Infection control is crucial for LT and an intensive medical care network led to successful living-donor LT.

Keywords

Liver transplantation Staphylococcus aureus Skin rash Septic pulmonary embolism 

Notes

Compliance with ethical standards

Conflict of interest

Professor Katsutoshi Tokushige received research fundings from Sumitomo Dainippon Pharma Co., Ltd. Astellas Phama Inc. Eisai Co., Ltd. TAIHO Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd. Daiichi Sankyo Pharmaceutical Co., Ltd. AbbVie GK, Takeda Pharmaceutical Company Limited. Asahi Kasei Corporation. AJINOMOTO CO., Inc. Otsuka Pharmaceutical Co., Ltd. Other authors have no conflict of interest.

Human/animal rights

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from all patients for being included in the study.

References

  1. 1.
    Acharya SK. Management in acute liver failure. J Clin Exp Hepatol. 2015;5:104–15.CrossRefGoogle Scholar
  2. 2.
    Nakao M, Nakayama N, Uchida Y, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53:752–69.CrossRefGoogle Scholar
  3. 3.
    Lee WM, Stravitz RT, Larson AM. Introduction to the revised American association for the study of liver diseases position paper on acute liver failure 2011. Hepatology. 2012;55:965–7.CrossRefGoogle Scholar
  4. 4.
    Soyama A, Eguchi S, Egawa H. Liver transplantation in Japan. Liver Transpl. 2016;22:1401–7.CrossRefGoogle Scholar
  5. 5.
    Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRefGoogle Scholar
  6. 6.
    Kessler WR, Cummings OW, Eckert G, et al. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol. 2004;2:625–31.CrossRefGoogle Scholar
  7. 7.
    Yoshiba M, Sekiyama K, Inoue K, et al. Accurate prediction of fulminant hepatic failure in severe acute viral hepatitis: multicenter study. J Gastroenterol. 2002;37:916–21.CrossRefGoogle Scholar
  8. 8.
    Cropley A, Weltman M. The use of immunosuppression in autoimmune hepatitis: a current literature review. Clin Mol Hepatol. 2017;23:22–6.CrossRefGoogle Scholar
  9. 9.
    Montano-Loza AJ, Carpenter HA, Czaja AJ. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology. 2007;46:1138–45.CrossRefGoogle Scholar
  10. 10.
    Ichai P, Duclos-Vallee JC, Guettier C, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl. 2007;13:996–1003.CrossRefGoogle Scholar
  11. 11.
    McCormack MG, Smith AJ, Akram AN, et al. Staphylococcus aureus and the oral cavity: an overlooked source of carriage and infection? Am J Infect Control. 2015;43:35–7.CrossRefGoogle Scholar
  12. 12.
    Nesseler N, Launey Y, Aninat C, et al. Clinical review: the liver in sepsis. Crit Care. 2012;16:235.CrossRefGoogle Scholar
  13. 13.
    Yan J, Li S, Li S. The role of the liver in sepsis. Int Rev Immunol. 2014;33:498–510.CrossRefGoogle Scholar
  14. 14.
    Katz S, Jimenez MA, Lehmkuhler WE, et al. Liver bacterial clearance following hepatic artery ligation and portacaval shunt. J Surg Res. 1991;51:267–70.CrossRefGoogle Scholar
  15. 15.
    Eguchi Y, Sugimoto H. Septicaemia. Jpn J Acute Med. 2003;27:576–7.Google Scholar
  16. 16.
    Cook RJ, Ashton RW, Aughenbaugh GL, et al. Septic pulmonary embolism: presenting features and clinical course of 14 patients. Chest. 2005;128:162–6.CrossRefGoogle Scholar
  17. 17.
    Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128.CrossRefGoogle Scholar
  18. 18.
    Murray RJ. Staphylococcus aureus infective endocarditis: diagnosis and management guidelines. Intern Med J. 2005;35:25–44.CrossRefGoogle Scholar
  19. 19.
    Abid Q, Price D, Stewart MJ, et al. Septic pulmonary emboli caused by a hemodialysis catheter. Asian Cardiovasc Thorac Ann. 2002;10:251–3.CrossRefGoogle Scholar
  20. 20.
    Ye R, Zhao L, Wang C, et al. Clinical characteristics of septic pulmonary embolism in adults: a systematic review. Respir Med. 2014;108:1–8.CrossRefGoogle Scholar
  21. 21.
    MacMillan JC, Milstein SH, Samson PC. Clinical spectrum of septic pulmonary embolism and infarction. J Thorac Cardiovasc Surg. 1977;75:670–9.Google Scholar
  22. 22.
    Takeda K, Tanaka K, Kumamoto T, et al. Septic pulmonary embolism originated from subcutaneous abscess after living donor liver transplantation: a pitfall of postoperative management. Clin J Gastroenterol. 2013;6:378–82.CrossRefGoogle Scholar
  23. 23.
    Golpe R, Marin B, Alonso M. Lemierre’s syndrome (necrobacillosis). Postgrad Med J. 1999;75:141–4.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Gastroenterology 2018

Authors and Affiliations

  1. 1.Department of Internal Medicine, Institute of GastroenterologyTokyo Women’s Medical UniversityTokyoJapan
  2. 2.Division of Gastroenterology, Department of Internal MedicineShowa University Fujigaoka HospitalYokohamaJapan
  3. 3.Division of Diagnostic PathologyShonan Fujisawa Tokushuukai HospitalFujisawa-shiJapan
  4. 4.Department of Surgery, Institute of GastroenterologyTokyo Women’s Medical UniversityTokyoJapan

Personalised recommendations